# Control of retrotransposon-driven activation of the interferon response by the double-stranded RNA binding protein DGCR8

**Authors:** Ana Gázquez-Gutiérrez, Priscilla Chin, Guillermo Peris, Katrina Gordon, Pilar G Marchante, Jeroen Witteveldt, Pablo Tristán-Ramos, Jerome O Rouvière, Lisanne I Knol, Alasdair Ivens, Lourdes López-Onieva, Antonio M Estévez, William Garland, Torben H Jensen, Sara R Heras, Sara Macias

PMC · DOI: 10.1093/nar/gkag190 · 2026-03-05

## TL;DR

This paper shows how DGCR8 protein prevents the immune system from overreacting by controlling RNA structures from transposable elements.

## Contribution

The study reveals DGCR8's role in suppressing endogenous dsRNA to prevent excessive interferon responses.

## Key findings

- DGCR8 inactivation unleashes the type I interferon response in human cells.
- DGCR8 resolves dsRNA structures from transposable elements in mRNAs.
- Low DGCR8 levels in 22q11.2 deletion syndrome correlate with heightened interferon activity.

## Abstract

The type I interferon (IFN) response is the main innate immune pathway against viruses in mammals. This pathway must be tightly regulated to prevent viral spread while avoiding excessive immune responses. Here, we show that inactivation of the double-stranded RNA (dsRNA)-binding protein DGCR8 unleashes the IFN response in human cells. We demonstrate that DGCR8 restricts the accumulation of endogenous dsRNA originating from protein-coding mRNAs that harbour transposable elements (TEs), primarily LINE and SINE elements. We propose that DGCR8 binding to TE-rich mRNAs is essential to resolve dsRNA structures, and in its absence, accumulated dsRNA signals through the MDA5-MAVS pathway trigger the IFN response. This mechanism is relevant to conditions where DGCR8 expression levels are altered, including the 22q11.2 deletion syndrome (22qDS). Supporting this, we show that 22qDS-derived cells exhibit an exacerbated type I IFN response, which inversely correlated with DGCR8 levels. All these together demonstrate the importance of suppressing endogenous TE-dsRNA accumulation to prevent unwanted immune activation and associated disease pathogenesis.

Graphical Abstract

## Linked entities

- **Genes:** DGCR8 (DGCR8 microprocessor complex subunit) [NCBI Gene 54487]
- **Proteins:** DGCR8 (DGCR8 microprocessor complex subunit)
- **Diseases:** 22q11.2 deletion syndrome (MONDO:0008564)

## Full-text entities

- **Genes:** IFNB1 (interferon beta 1) [NCBI Gene 3456] {aka IFB, IFF, IFN-beta, IFNB}, ADAR (adenosine deaminase RNA specific) [NCBI Gene 103] {aka ADAR1, AGS6, DRADA, DSH, DSRAD, G1P1}, DHX9 (DExH-box helicase 9) [NCBI Gene 1660] {aka DDX9, LKP, MRD75, NDH2, NDHII, RHA}, H2ax (H2A.X variant histone) [NCBI Gene 15270] {aka H2A.X, H2afx, Hist5-2ax, gammaH2ax}, VCL (vinculin) [NCBI Gene 7414] {aka CMD1W, CMH15, HEL114, MV, MVCL, VINC}, EIF2AK2 (eukaryotic translation initiation factor 2 alpha kinase 2) [NCBI Gene 5610] {aka PKR, PPP1R83, PRKR}, ZCCHC8 (zinc finger CCHC-type containing 8) [NCBI Gene 55596] {aka PFBMFT5}, STING1 (stimulator of interferon response cGAMP interactor 1) [NCBI Gene 340061] {aka ERIS, MITA, MPYS, NET23, SAVI, STING}, drosha (drosha ribonuclease III) [NCBI Gene 567505] {aka im:7150667, rnasen, zgc:158612}, RN7SK (RNA component of 7SK nuclear ribonucleoprotein) [NCBI Gene 125050] {aka 7SK}, IFNA1 (interferon alpha 1) [NCBI Gene 3439] {aka IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA13, IFNA@}, DGCR8 [NCBI Gene 101096112], STAT1 (signal transducer and activator of transcription 1) [NCBI Gene 6772] {aka CANDF7, IMD31A, IMD31B, IMD31C, ISGF-3, STAT91}, DROSHA (drosha ribonuclease III) [NCBI Gene 29102] {aka ETOHI2, HSA242976, RANSE3L, RN3, RNASE3L, RNASEN}, IFIT3 (interferon induced protein with tetratricopeptide repeats 3) [NCBI Gene 3437] {aka CIG-49, GARG-49, IFI60, IFIT4, IRG2, ISG60}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, MX1 (MX dynamin like GTPase 1) [NCBI Gene 4599] {aka IFI-78K, IFI78, MX, MxA, lncMX1-215}, EIF2A (eukaryotic translation initiation factor 2A) [NCBI Gene 83939] {aka CDA02, EIF-2A, MST089, MSTP004, MSTP089}, Mavs (mitochondrial antiviral signaling protein) [NCBI Gene 228607] {aka D430028G21Rik, IPS-1, Visa, cardif}, Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, Dgcr8 (DGCR8, microprocessor complex subunit) [NCBI Gene 94223] {aka D16H22S1742E, D16H22S788E, D16Wis2, Gy1, N41, Vo59c07}, ifih1 (interferon induced with helicase C domain 1) [NCBI Gene 565759] {aka MDA5a, MDA5b, si:dkey-81j5.2}, DGCR8 (DGCR8 microprocessor complex subunit) [NCBI Gene 54487] {aka C22orf12, DGCRK6, Gy1, pasha}, Dhx9 (DExH-box helicase 9) [NCBI Gene 13211] {aka Ddx9, HEL-5, NDHII, RHA, mHEL-5}, OAS3 (2'-5'-oligoadenylate synthetase 3) [NCBI Gene 4940] {aka p100, p100OAS}, Rigi (RNA sensor RIG-I) [NCBI Gene 230073] {aka 6430573D20Rik, C330021E21, Ddx58, RIG-I, RLR-1}, Lif (leukemia inhibitory factor) [NCBI Gene 16878], MAVS (mitochondrial antiviral signaling protein) [NCBI Gene 57506] {aka CARDIF, IPS-1, IPS1, VISA}, Vcl (vinculin) [NCBI Gene 22330] {aka 9430097D22}, Blnk (B cell linker) [NCBI Gene 17060] {aka BASH, Bca, Ly-57, Ly57, Lyw-57, SLP-65}, TBK1 (TANK binding kinase 1) [NCBI Gene 29110] {aka AIARV, FTDALS4, IIAE8, NAK, T2K}, Zcchc8 (zinc finger, CCHC domain containing 8) [NCBI Gene 70650] {aka 5730565F05Rik}, CGAS (cyclic GMP-AMP synthase) [NCBI Gene 115004] {aka C6orf150, D4, MB21D1, h-cGAS}, ifnphi1 (interferon phi 1) [NCBI Gene 360134] {aka ifn, ifn1, ifnab}, Ifit3 (interferon-induced protein with tetratricopeptide repeats 3) [NCBI Gene 15959] {aka Ifi49, P49}, IFIT2 (interferon induced protein with tetratricopeptide repeats 2) [NCBI Gene 3433] {aka G10P2, GARG-39, IFI-54, IFI-54K, IFI54, IFIT-2}, IRF3 (interferon regulatory factor 3) [NCBI Gene 3661] {aka IIAE7}, IFIH1 (interferon induced with helicase C domain 1) [NCBI Gene 64135] {aka AGS7, Hlcd, IDDM19, IMD95, MDA-5, MDA5}, RIGI (RNA sensor RIG-I) [NCBI Gene 23586] {aka DDX58, RIG-I, RIG1, RLR-1, SGMRT2}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, STAT2 (signal transducer and activator of transcription 2) [NCBI Gene 6773] {aka IMD44, ISGF-3, P113, PTORCH3, STAT113}, EEF1A2 (eukaryotic translation elongation factor 1 alpha 2) [NCBI Gene 1917] {aka DEE33, EEF1AL, EF-1-alpha-2, EF1A, EIEE33, HS1}, Drosha (drosha, ribonuclease type III) [NCBI Gene 14000] {aka 1110013A17Rik, Etohi2, Rn3, Rnasen}
- **Diseases:** HIV/AIDS (MESH:D015658), autoimmune and autoinflammatory diseases (MESH:D056660), genetic and/ (MESH:D030342), TE (MESH:C565217), autoimmune diseases (MESH:D001327), neuronal disorders (MESH:D009410), type I interferonopathies (MESH:D006969), Immunological abnormalities (MESH:D007154), 22q deletion syndrome (MESH:D002872), respiratory syncytial virus (MESH:D018357), Infections (MESH:D007239), 22q11.2 (MESH:D004062), dysfunction of the central nervous system (MESH:D002493), schizophrenia (MESH:D012559), neuroinflammation (MESH:D000090862), embryonic teratocarcinoma (MESH:D018243), inflammatory (MESH:D007249), Aicardi-Goutieres syndrome (MESH:C535607), Viral infection (MESH:D014777), immunodeficiencies (MESH:D007153)
- **Chemicals:** isopropanol (MESH:D019840), SDS (MESH:D012967), Alexa Fluor 555 (MESH:C000608607), PVDF (MESH:C024865), biotin (MESH:D001710), Tween 20 (MESH:D011136), TBS-T (MESH:C027647), Essential Amino Acids (MESH:D000601), PBS (MESH:D007854), DTT (MESH:D004229), guanidine hydrochloride (MESH:D019791), BX-795 (MESH:C579675), RUXO (MESH:C540383), Glutamax (MESH:C054122), Glucose (MESH:D005947), DMSO (MESH:D004121), DAPI (MESH:C007293), CO2 (MESH:D002245), EGTA (MESH:D004533), hygromycin B (MESH:D006921), L-glutamine (MESH:D005973), phenol (MESH:D019800), lamivudine (MESH:D019259), Trizol (MESH:C411644), TBS (MESH:D013725), Peptides (MESH:D010455), Polybrene (MESH:D006583), chloroform (MESH:D002725), sucrose (MESH:D013395), paraformaldehyde (MESH:C003043), CHIR99021 (MESH:C473711), poly(I:C) (MESH:D011070), EDTA (MESH:D004492), N2 (MESH:D009584), F12 (MESH:C007782), NP-40 (MESH:C010615), phenylmethyl-sulfonyl fluoride (MESH:D010664), DPBS (MESH:C012939), Lipofectamine 2000 (MESH:C086724), streptomycin (MESH:D013307), TPCK (MESH:D014108), Alexa Fluor 488 (MESH:C000711379), etoposide (MESH:D005047), acetonitrile (MESH:C032159), Triton X-100 (MESH:D017830), TFA (MESH:D014269), chloroacetamide (MESH:C013874), NaCl (MESH:D012965), MgCl2 (MESH:D015636), 2i (-), penicillin (MESH:D010406), puromycin (MESH:D011691), PD0325901 (MESH:C506614), HEPES (MESH:D006531), TCEP (MESH:C080938), DIC (MESH:D003606), actinomycin (MESH:D003609)
- **Species:** Influenza A virus (no rank) [taxon 11320], Mus musculus (house mouse, species) [taxon 10090], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Respiratory syncytial virus (no rank) [taxon 12814], Danio rerio (leopard danio, species) [taxon 7955], Escherichia coli (E. coli, species) [taxon 562]
- **Mutations:** D10A
- **Cell lines:** GM02944 — Homo sapiens (Human), 22q11.2 deletion syndrome, Finite cell line (CVCL_X274), CRL2429 — Homo sapiens (Human), Induced pluripotent stem cell (CVCL_ZA05), K562 — Homo sapiens (Human), Blast phase chronic myelogenous leukemia, BCR-ABL1 positive, Cancer cell line (CVCL_0004), BV-2 — Mus musculus (Mouse), Transformed cell line (CVCL_0182), HeLa — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0030), HEp-2 — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_1906), HEK293T — Homo sapiens (Human), Transformed cell line (CVCL_0063), HepG2 — Homo sapiens (Human), Hepatoblastoma, Cancer cell line (CVCL_0027), GM07215F — Homo sapiens (Human), 22q11.2 deletion syndrome, Finite cell line (CVCL_2Y98), PA-1 — Homo sapiens (Human), Transformed cell line (CVCL_E800), E14TG2a — Mus musculus (Mouse), Embryonic stem cell (CVCL_9108), MDCK — Canis lupus familiaris (Dog), Spontaneously immortalized cell line (CVCL_0422)

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12961426/full.md

---
Source: https://tomesphere.com/paper/PMC12961426